biotech

Hephaistos-Pharma is developing a new generation of immunostimulant to treat metastatic and hardly accessible tumors

Alga Therpeutics produces cancer-fighting antibodies from micro-algae.

Abcely develops innovative medical and pharmaceutical technologies for the treatment of mucosal cancers.

Odimma develops personalized immunotherapy using AI and synthetic DNA technology.

Kimialys offers an innovative, patented chemical coating that improves the reliability of diagnostic tests.

Plantibodies develops and produces monoclonal antibodies from plants in large quantities, at lower cost and with greater safety.

Development of the first intranasal vaccine against bronchiolitis and viral pneumonia caused by human metapneumovirus and RSV.

GAOMA Therapeutics est une société de biotechnologie développant des lipides en tant que nouveaux médicaments, avec un accent particulier sur l’épilepsie et les troubles cognitifs.

Apmonia Therapeutics is developing a pipeline of next-generation peptide therapies targeting the tumor microenvironment to improve the lives of cancer patients.

Omini develops the 1st multiplex blood testing platform for personalized medicine, using biosensors.